Evidence for a novel in vivo control mechanism of granulopoiesis: mature cell-related control of a regulatory growth factor

1989 - ashpublications.org
As part of phase I/II clinical trials of granulocyte colony-stimulating factor (G-CSF), the
pharmacokinetics was studied. To determine the optimal way of abrogating the neutropenia …

[PDF][PDF] Evidence for a Novel In Vivo Control Mechanism of Granulopoiesis: Mature Cell-Related Control of a Regulatory Growth Factor

JE Layton, H Hockman, WP Sheridan, G Morstyn - Blood, 1989 - academia.edu
MATERIALS AND METHODS Patients. The characteristics of the patients participating in the
phase I/Il trial of prevention of neutropenia caused by melphalan were previously …

Evidence for a novel in vivo control mechanism of granulopoiesis: mature cell-related control of a regulatory growth factor

JE Layton, H Hockman, WP Sheridan, G Morstyn - Blood, 1989 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> As part of phase I/II clinical trials of granulocyte
colony-stimulating factor (G-CSF), the pharmacokinetics was studied. To determine the …

[引用][C] Evidence for a novel in vivo control mechanism of granulopoiesis: mature cell-related control of a regulatory growth factor

JE LAYTON, H HOCKMAN, WP SHERIDAN… - Blood, 1989 - pascal-francis.inist.fr
Evidence for a novel in vivo control mechanism of granulopoiesis: mature cell-related
control of a regulatory growth factor CNRS Inist Pascal-Francis CNRS Pascal and Francis …

[PDF][PDF] Evidence for a novel in vivo control mechanism of granulopoiesis: mature

JE Layton, H Hockman, WP Sheridan, G Morstyn - Blood, 1989 - researchgate.net
MATERIALS AND METHODS Patients. The characteristics of the patients participating in the
phase I/Il trial of prevention of neutropenia caused by melphalan were previously …

Evidence for a novel in vivo control mechanism of granulopoiesis: mature cell-related control of a regulatory growth factor

JE Layton, H Hockman, WP Sheridan, G Morstyn - Blood, 1989 - pubmed.ncbi.nlm.nih.gov
As part of phase I/II clinical trials of granulocyte colony-stimulating factor (G-CSF), the
pharmacokinetics was studied. To determine the optimal way of abrogating the neutropenia …

Evidence for a novel in vivo control mechanism of granulopoiesis: mature cell-related control of a regulatory growth factor.

JE Layton, H Hockman, WP Sheridan, G Morstyn - Blood, 1989 - europepmc.org
As part of phase I/II clinical trials of granulocyte colony-stimulating factor (G-CSF), the
pharmacokinetics was studied. To determine the optimal way of abrogating the neutropenia …

[HTML][HTML] Evidence for a Novel In Vivo Control Mechanism of Granulopoiesis: Mature Cell-Related Control of a Regulatory Growth Factor

JE Layton, H Hockman, WP Sheridan, G Morstyn - Blood, 1989 - Elsevier
As part of phase I/II clinical trials of granulocyte colony-stimulating factor (G-CSF), the
pharmacokinetics was studied. To determine the optimal way of abrogating the neutropenia …

[引用][C] Evidence for a novel in vivo control mechanism of granulopoiesis: Mature cell-related control of a regulatory growth factor

L JE - Blood, 1989 - cir.nii.ac.jp
Evidence for a novel in vivo control mechanism of granulopoiesis : Mature cell-related
control of a regulatory growth factor | CiNii Research CiNii 国立情報学研究所 学術情報 …

[PDF][PDF] Evidence for a Novel In Vivo Control Mechanism of Granulopoiesis: Mature Cell-Related Control of a Regulatory Growth Factor

JE Layton, H Hockman, WP Sheridan, G Morstyn - Blood, 1989 - academia.edu
MATERIALS AND METHODS Patients. The characteristics of the patients participating in the
phase I/Il trial of prevention of neutropenia caused by melphalan were previously …